Matching articles for "Page 55"
Issue 1342 · July 12, 2010
Pralatrexate (Folotyn) for Peripheral T-Cell Lymphoma

The FDA has approved pralatrexate ( Folotyn – Allos), an intravenous (IV) antifolate, for treatment of adults with relapsed or refractory peripheral T-cell lymphoma (PTCL). It is the first drug approved by…

Med Lett Drugs Ther. 2010 Jul 12; 52(1342):55-6
The FDA has approved pralatrexate ( Folotyn – Allos), an intravenous (IV) antifolate, for treatment of adults with relapsed or refractory peripheral T-cell lymphoma (PTCL). It is the first drug approved by the FDA specifically for this indication.
Issue 1316 · July 13, 2009
Golimumab (Simponi) for Inflammatory Arthritis

Golimumab ( Simponi - Centocor), a fully humanized anti-tumor necrosis factor (TNF)-a antibody, has been approved by the FDA for the treatment of: (1) moderate to severe active rheumatoid arthritis (RA) in…

Med Lett Drugs Ther. 2009 Jul 13; 51(1316):55-6
Golimumab ( Simponi - Centocor), a fully humanized anti-tumor necrosis factor (TNF)-a antibody, has been approved by the FDA for the treatment of: (1) moderate to severe active rheumatoid arthritis (RA) in combination with methotrexate; (2) active psoriatic arthritis (PsA) alone or in combination with methotrexate; and (3) active ankylosing spondylitis (AS).
Issue 1292 · August 11, 2008 Free
Correction: The EarCheck Middle Ear Monitor

The article in the July 14th issue contained an error in the last sentence of the last paragraph beginning on page 55. The instrument's reading is determined not by the degree of protrusion of the tympanic…

Med Lett Drugs Ther. 2008 Aug 11; 50(1292):64
The article in the July 14th issue contained an error in the last sentence of the last paragraph beginning on page 55. The instrument's reading is determined not by the degree of protrusion of the tympanic membrane, but rather by its mobility.
Issue 72 · August 1, 2008
Treatment of Peptic Ulcers and GERD

Peptic ulcers caused by treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) are mainly gastric ulcers. Most duodenal and other gastric ulcers are caused by the gram-negative bacillus Helicobacter…

Treat Guidel Med Lett. 2008 Aug; 6(72):55-60
Peptic ulcers caused by treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) are mainly gastric ulcers. Most duodenal and other gastric ulcers are caused by the gram-negative bacillus Helicobacter pylori. Gastroesophageal reflux disease (GERD) is caused by gastric acid reflux into the esophagus. Drugs that suppress gastric acid production are the primary treatment for GERD and peptic ulcers.
Issue 1290 · July 14, 2008
The EarCheck Middle Ear Monitor for Detection of Middle Ear Effusion in Children

The EarCheck Middle Ear Monitor (Innovia Medical) is a device marketed to consumers for home detection of middle-ear effusion (MEE) in children.

Med Lett Drugs Ther. 2008 Jul 14; 50(1290):55-6
The EarCheck Middle Ear Monitor (Innovia Medical) is a device marketed to consumers for home detection of middle-ear effusion (MEE) in children.
Issue 1264 · July 2, 2007
Resperate for Hypertension

The FDA has approved the marketing of Resperate (InterCure), a device that helps patients breathe slowly, as an adjunct for treatment of hypertension. The FDA does not require proof of effectiveness for…

Med Lett Drugs Ther. 2007 Jul 2; 49(1264):55-6
The FDA has approved the marketing of Resperate (InterCure), a device that helps patients breathe slowly, as an adjunct for treatment of hypertension. The FDA does not require proof of effectiveness for approval of devices with minimal potential for harm, such as this one.